A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaMark R. Gilbert, Minesh P. Mehta, Robert Jeraj et al.|New England Journal of Medicine|2014Cited by 2.8k
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Jason T. Huse, Promita Bose et al.|Nature Communications|2018Cited by 90
A gene expression signature predicts recurrence-free survival in meningiomaAdriana Olar, Erik P. Sulman|Oncotarget|2018Cited by 31
Outcomes of Radiosurgery for WHO Grade 2 Meningiomas: The Role of Ki-67 Index in Guiding the Tumor Margin DoseYing Meng, Douglas Kondziolka, Kenneth E. Bernstein et al.|Neurosurgery|2024Cited by 7
Integral Dose or Mean Dose for Predicting Radiosurgery Response in Patients With Trigeminal Neuralgia: A Proposal to Target the Narrowest Part of the NerveYing Meng, Douglas Kondziolka, Brandon Santhumayor et al.|Neurosurgery|2024Cited by 2